Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

14.5K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.5K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

4.0K
4.0K
Types of RNA01:20

Types of RNA

8.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.7K
Types of RNA01:23

Types of RNA

72.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Honoring Dr. Angelo Azzi's legacy and expanding the horizons of Molecular Aspects of Medicine.

Molecular aspects of medicine·2026
Same author

β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell Carcinoma.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

MicroRNAs in oncology: a translational perspective in the era of AI.

Nature reviews. Clinical oncology·2026
Same author

Transposable Element-Derived miR-28-5p and miR-708-5p: Exploring Potential Roles in Lung Cancer.

Non-coding RNA·2025
Same author

MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapy.

Cancer drug resistance (Alhambra, Calif.)·2025
Same author

Deconvolution of Sparse-count RNA Sequencing Data for Tumor Cells Using Embedded Negative Binomial Distributions.

bioRxiv : the preprint server for biology·2025
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes
09:45

An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes

Published on: August 18, 2018

11.5K

When non-coding is not enough.

Simone Anfossi, George A Calin1

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.

The Journal of Experimental Medicine
|February 6, 2020
PubMed
Summary
This summary is machine-generated.

Researchers discovered a new peptide, ASRPS, encoded by a long non-coding RNA (lncRNA). This peptide inhibits angiogenesis, a key process in triple-negative breast cancer (TNBC) development.

More Related Videos

Enhanced Northern Blot Detection of Small RNA Species in Drosophila Melanogaster
09:39

Enhanced Northern Blot Detection of Small RNA Species in Drosophila Melanogaster

Published on: August 21, 2014

24.6K
Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

8.7K

Related Experiment Videos

Last Updated: Dec 29, 2025

An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes
09:45

An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes

Published on: August 18, 2018

11.5K
Enhanced Northern Blot Detection of Small RNA Species in Drosophila Melanogaster
09:39

Enhanced Northern Blot Detection of Small RNA Species in Drosophila Melanogaster

Published on: August 21, 2014

24.6K
Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

8.7K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Non-coding RNAs (ncRNAs) are increasingly recognized for their roles beyond structural or regulatory functions.
  • A growing number of ncRNAs are found to encode biologically active short peptides.
  • Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with limited targeted therapies.

Purpose of the Study:

  • To identify and characterize novel functional peptides encoded by long non-coding RNAs (lncRNAs).
  • To investigate the biological activity of a newly identified lncRNA-encoded peptide in the context of cancer.
  • To explore the potential of this peptide as a therapeutic target for triple-negative breast cancer (TNBC).

Main Methods:

  • Bioinformatic analysis to identify potential peptide-coding regions within lncRNAs.
  • Molecular cloning and expression of the identified lncRNA-encoded polypeptide.
  • In vitro assays to assess the biological activity, specifically focusing on angiogenesis inhibition.
  • Cell-based assays using TNBC models to evaluate anti-cancer effects.

Main Results:

  • Identification of a 60-amino acid polypeptide, named ASRPS, encoded by a long non-coding RNA.
  • Demonstration that ASRPS inhibits angiogenesis, a critical process for tumor growth and metastasis.
  • Evidence suggesting ASRPS's efficacy in preclinical models of triple-negative breast cancer (TNBC).

Conclusions:

  • Long non-coding RNAs can encode functional peptides with significant biological activities.
  • The lncRNA-encoded peptide ASRPS represents a novel inhibitor of angiogenesis.
  • ASRPS shows therapeutic potential for treating triple-negative breast cancer (TNBC).